Bristol Myers Squibb Strengthens Cell Therapy Capabilities by Adding New U.S. Manufacturing Facility for Viral Vector Production Pharmaceutical Investing
Johnson & Johnson to Participate in the Bernstein 39th Annual Strategic Decisions Conference Pharmaceutical Investing
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. , BELLUS Health Inc , Prometheus Biosciences, Inc. , Univar Solutions Inc. Life Science Investing
Toni Braxton and Aurinia Want People with Lupus Nephritis to Get Uncomfortable to Protect their Kidneys Life Science Investing
Salix Partners with the Colorectal Cancer Alliance on Community Screening Program Pharmaceutical Investing
Plaintiffs' Attorneys Representing Talc-Cancer Victims Form Ad Hoc Committee to Support J&J Settlement Pharmaceutical Investing
AbbVie Announces Late-Breaking Results from Phase 3 Trial Evaluating Atogepant for the Preventive Treatment of Episodic Migraine Among Patients with Prior Treatment Failure at the 2023 AAN Annual Meeting Pharmaceutical Investing
